Inj., bendeka 1 mg
Products billed under this code include Bendeka.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Bendeka.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Bendeka | Cephalon, LLC | 63459-0348-04 | 100 | $1,142.20 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $11.422 | −$1.11 | 1 MG | Inj., bendeka 1 mg | v1, posted September 17, 2026 |
| 3Q26 | $12.532 | −$0.369 | 1 MG | Inj., bendeka 1 mg | v1, posted September 15, 2026 |
| 2Q26 | $12.901 | +$0.067 | 1 MG | Inj., bendeka 1 mg | v1, posted September 15, 2026 |
| 1Q26 | $12.834 | −$0.654 | 1 MG | Inj., bendeka 1 mg | v1, posted September 15, 2026 |
| 4Q25 | $13.488 | +$0.368 | 1 MG | Inj., bendeka 1 mg | v1, posted September 8, 2026 |
| 3Q25 | $13.12 | −$0.461 | 1 MG | Inj., bendeka 1 mg | v1, posted March 10, 2026 |
| 2Q25 | $13.581 | +$0.128 | 1 MG | Inj., bendeka 1 mg | v1, posted March 10, 2026 |
| 1Q25 | $13.453 | +$0.507 | 1 MG | Inj., bendeka 1 mg | v1, posted December 19, 2025 |
| 4Q24 | $12.946 | −$0.668 | 1 MG | Inj., bendeka 1 mg | v1, posted June 11, 2025 |
| 3Q24 | $13.614 | −$0.217 | 1 MG | Inj., bendeka 1 mg | v1, posted June 11, 2025 |
| 2Q24 | $13.831 | −$0.925 | 1 MG | Inj., bendeka 1 mg | v1, posted March 11, 2025 |
| 1Q24 | $14.756 | −$1.105 | 1 MG | Inj., bendeka 1 mg | v1, posted December 19, 2024 |
| 4Q23 | $15.861 | −$0.647 | 1 MG | Inj., bendeka 1 mg | v1, posted October 10, 2024 |
| 3Q23 | $16.508 | −$0.398 | 1 MG | Inj., bendeka 1 mg | v1, posted June 5, 2024 |
| 2Q23 | $16.906 | +$0.097 | 1 MG | Inj., bendeka 1 mg | v1, posted February 23, 2024 |
| 1Q23 | $16.809 | −$0.625 | 1 MG | Inj., bendeka 1 mg | v1, posted December 6, 2023 |
| 4Q22 | $17.434 | −$0.409 | 1 MG | Inj., bendeka 1 mg | v1, posted June 22, 2023 |
| 3Q22 | $17.843 | −$0.709 | 1 MG | Inj., bendeka 1 mg | v1, posted June 9, 2023 |
| 2Q22 | $18.552 | −$0.524 | 1 MG | Inj., bendeka 1 mg | v1, posted December 14, 2022 |
| 1Q22 | $19.076 | −$0.57 | 1 MG | Inj., bendeka 1 mg | v1, posted June 8, 2022 |
| 4Q21 | $19.646 | +$0.001 | 1 MG | Inj., bendeka 1 mg | v1, posted June 2, 2022 |
| 3Q21 | $19.645 | +$0.069 | 1 MG | Inj., bendeka 1 mg | v1, posted June 2, 2022 |
| 2Q21 | $19.576 | −$0.597 | 1 MG | Inj., bendeka 1 mg | v1, posted March 1, 2022 |
| 1Q21 | $20.173 | – | 1 MG | Inj., bendeka 1 mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.